Seikagaku Corporation (TYO:4548)

Market Cap	38.93B +5.8%
Revenue (ttm)	36.75B -3.5%
Net Income	1.66B
EPS	30.44
Shares Out	54.60M
PE Ratio	23.42
Forward PE	n/a
Dividend	30.00 (4.23%)
Ex-Dividend Date	Sep 29, 2026

Volume	96,400
Open	714.00
Previous Close	713.00
Day's Range	714.00 - 724.00
52-Week Range	644.00 - 820.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the ARTZ, ARTZ Dispo, VISCO-3, JOYCLU, Gel-One, Hylink, and SUPARTZ brands; ophthalmic surgical aids under the OPEGAN and SHELLGAN brand names; surgical aids for endoscopic mucosal resection under the brand nam...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,142
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In fiscal year 2026, Seikagaku's revenue was 36.65 billion, a decrease of -6.93% compared to the previous year's 39.37 billion. Earnings were 1.47 billion, an increase of 21.33%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error